{"id":3322,"date":"2021-11-25T15:21:44","date_gmt":"2021-11-25T14:21:44","guid":{"rendered":"https:\/\/www.curavac.com\/notre-technologie"},"modified":"2025-04-04T10:51:16","modified_gmt":"2025-04-04T08:51:16","slug":"notre-technologie","status":"publish","type":"page","link":"https:\/\/www.curavac.com\/fr\/notre-technologie","title":{"rendered":"Notre technologie"},"content":{"rendered":"<style>\/*! elementor - v3.6.8 - 27-07-2022 *\/\n.e-container.e-container--row .elementor-spacer-inner{width:var(--spacer-size)}.e-container.e-container--column .elementor-spacer-inner,.elementor-column .elementor-spacer-inner{height:var(--spacer-size)}<\/style>\n<style>\/*! elementor - v3.6.8 - 27-07-2022 *\/\n.elementor-heading-title{padding:0;margin:0;line-height:1}.elementor-widget-heading .elementor-heading-title[class*=elementor-size-]>a{color:inherit;font-size:inherit;line-height:inherit}.elementor-widget-heading .elementor-heading-title.elementor-size-small{font-size:15px}.elementor-widget-heading .elementor-heading-title.elementor-size-medium{font-size:19px}.elementor-widget-heading .elementor-heading-title.elementor-size-large{font-size:29px}.elementor-widget-heading .elementor-heading-title.elementor-size-xl{font-size:39px}.elementor-widget-heading .elementor-heading-title.elementor-size-xxl{font-size:59px}<\/style>\n<h2>Notre technologie<\/h2>\n<style>\/*! elementor - v3.6.8 - 27-07-2022 *\/\n.elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=\".svg\"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block}<\/style>\n<p>\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" width=\"1024\" height=\"606\" src=\"https:\/\/www.curavac.com\/wp-content\/uploads\/2021\/11\/1837808365-huge-1024x606.jpg\" alt=\"\" loading=\"lazy\" srcset=\"https:\/\/www.curavac.com\/wp-content\/uploads\/2021\/11\/1837808365-huge-1024x606.jpg 1024w, https:\/\/www.curavac.com\/wp-content\/uploads\/2021\/11\/1837808365-huge-300x177.jpg 300w, https:\/\/www.curavac.com\/wp-content\/uploads\/2021\/11\/1837808365-huge-768x454.jpg 768w, https:\/\/www.curavac.com\/wp-content\/uploads\/2021\/11\/1837808365-huge-1536x908.jpg 1536w, https:\/\/www.curavac.com\/wp-content\/uploads\/2021\/11\/1837808365-huge-2048x1211.jpg 2048w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/p>\n<style>\/*! elementor - v3.6.8 - 27-07-2022 *\/\n.elementor-widget-divider{--divider-border-style:none;--divider-border-width:1px;--divider-color:#2c2c2c;--divider-icon-size:20px;--divider-element-spacing:10px;--divider-pattern-height:24px;--divider-pattern-size:20px;--divider-pattern-url:none;--divider-pattern-repeat:repeat-x}.elementor-widget-divider .elementor-divider{display:-webkit-box;display:-ms-flexbox;display:flex}.elementor-widget-divider .elementor-divider__text{font-size:15px;line-height:1;max-width:95%}.elementor-widget-divider .elementor-divider__element{margin:0 var(--divider-element-spacing);-ms-flex-negative:0;flex-shrink:0}.elementor-widget-divider .elementor-icon{font-size:var(--divider-icon-size)}.elementor-widget-divider .elementor-divider-separator{display:-webkit-box;display:-ms-flexbox;display:flex;margin:0;direction:ltr}.elementor-widget-divider--view-line_icon .elementor-divider-separator,.elementor-widget-divider--view-line_text .elementor-divider-separator{-webkit-box-align:center;-ms-flex-align:center;align-items:center}.elementor-widget-divider--view-line_icon .elementor-divider-separator:after,.elementor-widget-divider--view-line_icon .elementor-divider-separator:before,.elementor-widget-divider--view-line_text .elementor-divider-separator:after,.elementor-widget-divider--view-line_text .elementor-divider-separator:before{display:block;content:\"\";border-bottom:0;-webkit-box-flex:1;-ms-flex-positive:1;flex-grow:1;border-top:var(--divider-border-width) var(--divider-border-style) var(--divider-color)}.elementor-widget-divider--element-align-left .elementor-divider .elementor-divider-separator>.elementor-divider__svg:first-of-type{-webkit-box-flex:0;-ms-flex-positive:0;flex-grow:0;-ms-flex-negative:100;flex-shrink:100}.elementor-widget-divider--element-align-left .elementor-divider-separator:before{content:none}.elementor-widget-divider--element-align-left .elementor-divider__element{margin-left:0}.elementor-widget-divider--element-align-right .elementor-divider .elementor-divider-separator>.elementor-divider__svg:last-of-type{-webkit-box-flex:0;-ms-flex-positive:0;flex-grow:0;-ms-flex-negative:100;flex-shrink:100}.elementor-widget-divider--element-align-right .elementor-divider-separator:after{content:none}.elementor-widget-divider--element-align-right .elementor-divider__element{margin-right:0}.elementor-widget-divider:not(.elementor-widget-divider--view-line_text):not(.elementor-widget-divider--view-line_icon) .elementor-divider-separator{border-top:var(--divider-border-width) var(--divider-border-style) var(--divider-color)}.elementor-widget-divider--separator-type-pattern{--divider-border-style:none}.elementor-widget-divider--separator-type-pattern.elementor-widget-divider--view-line .elementor-divider-separator,.elementor-widget-divider--separator-type-pattern:not(.elementor-widget-divider--view-line) .elementor-divider-separator:after,.elementor-widget-divider--separator-type-pattern:not(.elementor-widget-divider--view-line) .elementor-divider-separator:before,.elementor-widget-divider--separator-type-pattern:not([class*=elementor-widget-divider--view]) .elementor-divider-separator{width:100%;min-height:var(--divider-pattern-height);-webkit-mask-size:var(--divider-pattern-size) 100%;mask-size:var(--divider-pattern-size) 100%;-webkit-mask-repeat:var(--divider-pattern-repeat);mask-repeat:var(--divider-pattern-repeat);background-color:var(--divider-color);-webkit-mask-image:var(--divider-pattern-url);mask-image:var(--divider-pattern-url)}.elementor-widget-divider--no-spacing{--divider-pattern-size:auto}.elementor-widget-divider--bg-round{--divider-pattern-repeat:round}.rtl .elementor-widget-divider .elementor-divider__text{direction:rtl}.e-container>.elementor-widget-divider{width:var(--container-widget-width,100%);-webkit-box-flex:1;-ms-flex-positive:1;flex-grow:1}<\/style>\n<p><strong>C<\/strong><b>uraVac<\/b> est une soci\u00e9t\u00e9 de biotechnologie au stade clinique qui d\u00e9veloppe le potentiel m\u00e9dical et commercial d&rsquo;une technique r\u00e9volutionnaire pour la production de th\u00e9rapies actives cibl\u00e9es (ou immunoth\u00e9rapies actives cibl\u00e9es) pour les maladies auto-immunes.<\/p>\n<p>Nous concentrons actuellement nos recherches sur la th\u00e9rapie active cibl\u00e9e contre la <a href=\"https:\/\/www.curavac.com\/fr\/myasthenie-grave\">myasth\u00e9nie grave (MG)<\/a>, une maladie auto-immune qui attaque la jonction neuromusculaire et alt\u00e8re sa capacit\u00e9 \u00e0 transmettre l&rsquo;influx nerveux pour d\u00e9clencher les contractions musculaires. Cela entra\u00eene une faiblesse musculaire extr\u00eame et rend difficile la r\u00e9alisation d&rsquo;actions telles que maintenir les paupi\u00e8res ouvertes, parler, avaler ou respirer.<\/p>\n<p>La cible de la r\u00e9ponse auto-immune erron\u00e9e dans la MG est le <b>r\u00e9cepteur de l&rsquo;ac\u00e9tylcholine<\/b> (AChr), une prot\u00e9ine membranaire int\u00e9grale responsable de la liaison au neurotransmetteur <strong>ac\u00e9tylcholine<\/strong> (ACh). Dans des situations normales, un influx nerveux induit la lib\u00e9ration d&rsquo;ACh \u00e0 la jonction neuromusculaire. L&rsquo;ACh se lie alors aux r\u00e9cepteurs qui, \u00e0 leur tour, s&rsquo;ouvrent et permettent aux ions de p\u00e9n\u00e9trer dans les cellules musculaires, induisant une contraction musculaire normale.<\/p>\n<p>Chez les personnes atteintes de myasth\u00e9nie, une r\u00e9gion des r\u00e9cepteurs de l&rsquo;ac\u00e9tylcholine, appel\u00e9e <strong>immunor\u00e9gion majeure<\/strong>, est mal orient\u00e9e et bloqu\u00e9e par des anticorps. Cela les rend inactifs et conduit finalement \u00e0 leur destruction par une cascade de r\u00e9actions biologiques.<\/p>\n<p>R\u00e9alisant que c&rsquo;est l\u00e0 que le traitement doit intervenir, et suite \u00e0 une d\u00e9couverte du professeur J. Edwin Blalock, CuraVac a r\u00e9ussi \u00e0 cr\u00e9er un peptide antig\u00e9nique compl\u00e9mentaire en examinant la <strong>s\u00e9quence de l&rsquo;ARNm<\/strong> de l&rsquo;immunor\u00e9gion principale et en d\u00e9terminant son <strong>sch\u00e9ma hydrophile\/hydrophobe.<\/strong> En <strong>inversant<\/strong> la s\u00e9quence d&rsquo;ARNm, nous avons obtenu le sch\u00e9ma inverse qui sert de base \u00e0 la fabrication de notre peptide compl\u00e9mentaire.<\/p>\n<p>Cet antig\u00e8ne peptidique compl\u00e9mentaire est ensuite simplement inject\u00e9 au patient par le biais de la th\u00e9rapie active cibl\u00e9e\u00a0afin d&rsquo;induire la cr\u00e9ation d&rsquo;anticorps compl\u00e9mentaires. Ces anticorps compl\u00e9mentaires se lient alors aux auto-anticorps incrimin\u00e9s, les rendant incapables de se connecter \u00e0 la r\u00e9gion immunitaire primaire des receveurs.<\/p>\n<p>https:\/\/youtu.be\/ZaTX3VmyJd4<\/p>\n<p>Gr\u00e2ce \u00e0 ce processus, les r\u00e9cepteurs d&rsquo;ac\u00e9tylcholine peuvent fonctionner correctement et <strong>une fonction neuromusculaire saine est r\u00e9tablie.<\/strong><\/p>\n<p>Les m\u00e9dicaments actuellement disponibles sur le march\u00e9 reposent sur des alt\u00e9rations agressives du syst\u00e8me immunitaire, ce qui r\u00e9duit souvent leur efficacit\u00e9 globale. Cela peut entra\u00eener de graves effets secondaires, sans pour autant gu\u00e9rir efficacement le patient. L&rsquo;approche de CuraVac consiste \u00e0 mettre au point un traitement capable de cibler uniquement la partie offensive du syst\u00e8me immunitaire, sans affecter les fonctions saines.<\/p>\n<p>\u00c0 terme, nous souhaitons d\u00e9velopper des traitements pour d&rsquo;autres maladies auto-immunes telles que la <strong>scl\u00e9rose en plaques (SEP)<\/strong>, <strong>le diab\u00e8te de type 1<\/strong>, <strong>la polyarthrite rhumato\u00efde<\/strong> et le <strong>lupus \u00e9ryth\u00e9mateux diss\u00e9min\u00e9 (LED)<\/strong>, en utilisant la m\u00eame technologie de peptides compl\u00e9mentaires.<\/p>\n<p>Notre plateforme r\u00e9volutionnaire de d\u00e9veloppement de peptides compl\u00e9mentaires a d\u00e9j\u00e0 d\u00e9montr\u00e9 son efficacit\u00e9 et son innocuit\u00e9 dans notre <a href=\"https:\/\/www.curavac.com\/wp-content\/uploads\/2021\/11\/Communication_CV-0002_Results_EN.pdf\" target=\"_blank\" rel=\"noopener\">essai clinique de phase 1 <\/a>portant sur une\u00a0th\u00e9rapie active cibl\u00e9e contre la myasth\u00e9nie grave, et nous recherchons actuellement des <a href=\"https:\/\/www.curavac.com\/fr\/investissements\" target=\"_blank\" rel=\"noopener\">investisseurs <\/a>pour financer notre essai clinique de phase 2.<\/p>\n<p>Le succ\u00e8s de la premi\u00e8re\u00a0th\u00e9rapie active cibl\u00e9e de CuraVac constitue une <strong>perc\u00e9e potentielle<\/strong> dans le domaine des maladies auto-immunes et pourrait ouvrir la voie \u00e0 un nouveau type de traitement. Un traitement qui pourrait offrir une am\u00e9lioration durable et apporter un rem\u00e8de potentiel aux personnes souffrant de maladies auto-immunes dans le monde entier.<\/p>\n<h5 style=\"text-align: center;\">Chez <strong>CuraVac<\/strong>, nous croyons au traitement de la maladie et non \u00e0 la th\u00e9rapie d&rsquo;entretien. Nous voulons <strong>traiter les patients pour toujours et ne pas traiter les patients pour toujours.<\/strong><\/h5>\n","protected":false},"excerpt":{"rendered":"<p>Notre technologie CuraVac est une soci\u00e9t\u00e9 de biotechnologie au stade clinique qui d\u00e9veloppe le potentiel m\u00e9dical et commercial d&rsquo;une technique r\u00e9volutionnaire pour la production de th\u00e9rapies actives cibl\u00e9es (ou immunoth\u00e9rapies actives cibl\u00e9es) pour les maladies auto-immunes. Nous concentrons actuellement nos recherches sur la th\u00e9rapie active cibl\u00e9e contre la myasth\u00e9nie grave (MG), une maladie auto-immune qui &hellip;<\/p>\n<p class=\"read-more\"> <a class=\"\" href=\"https:\/\/www.curavac.com\/fr\/notre-technologie\"> <span class=\"screen-reader-text\">Notre technologie<\/span> Lire la suite\u00a0\u00bb<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","footnotes":""},"class_list":["post-3322","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Notre technologie - CuraVac<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.curavac.com\/our-technology\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Notre technologie - CuraVac\" \/>\n<meta property=\"og:description\" content=\"Notre technologie CuraVac est une soci\u00e9t\u00e9 de biotechnologie au stade clinique qui d\u00e9veloppe le potentiel m\u00e9dical et commercial d&rsquo;une technique r\u00e9volutionnaire pour la production de th\u00e9rapies actives cibl\u00e9es (ou immunoth\u00e9rapies actives cibl\u00e9es) pour les maladies auto-immunes. Nous concentrons actuellement nos recherches sur la th\u00e9rapie active cibl\u00e9e contre la myasth\u00e9nie grave (MG), une maladie auto-immune qui &hellip; Notre technologie Lire la suite\u00a0\u00bb\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.curavac.com\/our-technology\" \/>\n<meta property=\"og:site_name\" content=\"CuraVac\" \/>\n<meta property=\"article:modified_time\" content=\"2025-04-04T08:51:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.curavac.com\/wp-content\/uploads\/2021\/11\/1837808365-huge-1024x606.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.curavac.com\/our-technology\",\"url\":\"https:\/\/www.curavac.com\/our-technology\",\"name\":\"Notre technologie - CuraVac\",\"isPartOf\":{\"@id\":\"https:\/\/www.curavac.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.curavac.com\/our-technology#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.curavac.com\/our-technology#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.curavac.com\/wp-content\/uploads\/2021\/11\/1837808365-huge-1024x606.jpg\",\"datePublished\":\"2021-11-25T14:21:44+00:00\",\"dateModified\":\"2025-04-04T08:51:16+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.curavac.com\/our-technology#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.curavac.com\/our-technology\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.curavac.com\/our-technology#primaryimage\",\"url\":\"https:\/\/www.curavac.com\/wp-content\/uploads\/2021\/11\/1837808365-huge-1024x606.jpg\",\"contentUrl\":\"https:\/\/www.curavac.com\/wp-content\/uploads\/2021\/11\/1837808365-huge-1024x606.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.curavac.com\/our-technology#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.curavac.com\/fr\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Notre technologie\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.curavac.com\/#website\",\"url\":\"https:\/\/www.curavac.com\/\",\"name\":\"CuraVac\",\"description\":\"Targeted Active Therapy for Autoimmune Diseases\",\"publisher\":{\"@id\":\"https:\/\/www.curavac.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.curavac.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.curavac.com\/#organization\",\"name\":\"CuraVac\",\"url\":\"https:\/\/www.curavac.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.curavac.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.curavac.com\/wp-content\/uploads\/2025\/04\/cropped-cropped-Taransparant-4.png\",\"contentUrl\":\"https:\/\/www.curavac.com\/wp-content\/uploads\/2025\/04\/cropped-cropped-Taransparant-4.png\",\"width\":1215,\"height\":331,\"caption\":\"CuraVac\"},\"image\":{\"@id\":\"https:\/\/www.curavac.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Notre technologie - CuraVac","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.curavac.com\/our-technology","og_locale":"fr_FR","og_type":"article","og_title":"Notre technologie - CuraVac","og_description":"Notre technologie CuraVac est une soci\u00e9t\u00e9 de biotechnologie au stade clinique qui d\u00e9veloppe le potentiel m\u00e9dical et commercial d&rsquo;une technique r\u00e9volutionnaire pour la production de th\u00e9rapies actives cibl\u00e9es (ou immunoth\u00e9rapies actives cibl\u00e9es) pour les maladies auto-immunes. Nous concentrons actuellement nos recherches sur la th\u00e9rapie active cibl\u00e9e contre la myasth\u00e9nie grave (MG), une maladie auto-immune qui &hellip; Notre technologie Lire la suite\u00a0\u00bb","og_url":"https:\/\/www.curavac.com\/our-technology","og_site_name":"CuraVac","article_modified_time":"2025-04-04T08:51:16+00:00","og_image":[{"url":"https:\/\/www.curavac.com\/wp-content\/uploads\/2021\/11\/1837808365-huge-1024x606.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.curavac.com\/our-technology","url":"https:\/\/www.curavac.com\/our-technology","name":"Notre technologie - CuraVac","isPartOf":{"@id":"https:\/\/www.curavac.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.curavac.com\/our-technology#primaryimage"},"image":{"@id":"https:\/\/www.curavac.com\/our-technology#primaryimage"},"thumbnailUrl":"https:\/\/www.curavac.com\/wp-content\/uploads\/2021\/11\/1837808365-huge-1024x606.jpg","datePublished":"2021-11-25T14:21:44+00:00","dateModified":"2025-04-04T08:51:16+00:00","breadcrumb":{"@id":"https:\/\/www.curavac.com\/our-technology#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.curavac.com\/our-technology"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.curavac.com\/our-technology#primaryimage","url":"https:\/\/www.curavac.com\/wp-content\/uploads\/2021\/11\/1837808365-huge-1024x606.jpg","contentUrl":"https:\/\/www.curavac.com\/wp-content\/uploads\/2021\/11\/1837808365-huge-1024x606.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.curavac.com\/our-technology#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.curavac.com\/fr"},{"@type":"ListItem","position":2,"name":"Notre technologie"}]},{"@type":"WebSite","@id":"https:\/\/www.curavac.com\/#website","url":"https:\/\/www.curavac.com\/","name":"CuraVac","description":"Targeted Active Therapy for Autoimmune Diseases","publisher":{"@id":"https:\/\/www.curavac.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.curavac.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.curavac.com\/#organization","name":"CuraVac","url":"https:\/\/www.curavac.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.curavac.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.curavac.com\/wp-content\/uploads\/2025\/04\/cropped-cropped-Taransparant-4.png","contentUrl":"https:\/\/www.curavac.com\/wp-content\/uploads\/2025\/04\/cropped-cropped-Taransparant-4.png","width":1215,"height":331,"caption":"CuraVac"},"image":{"@id":"https:\/\/www.curavac.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.curavac.com\/fr\/wp-json\/wp\/v2\/pages\/3322","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.curavac.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.curavac.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.curavac.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.curavac.com\/fr\/wp-json\/wp\/v2\/comments?post=3322"}],"version-history":[{"count":7,"href":"https:\/\/www.curavac.com\/fr\/wp-json\/wp\/v2\/pages\/3322\/revisions"}],"predecessor-version":[{"id":4620,"href":"https:\/\/www.curavac.com\/fr\/wp-json\/wp\/v2\/pages\/3322\/revisions\/4620"}],"wp:attachment":[{"href":"https:\/\/www.curavac.com\/fr\/wp-json\/wp\/v2\/media?parent=3322"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}